Related Experiment Videos

Pseudomonas pneumonia of mink: pathogenesis, vaccination, and serologic studies

Insights

Pseudomonas aeruginosa causes severe pneumonia in mink, leading to lung lesions and bacterial spread. Antibodies against Pseudomonas aeruginosa lipopolysaccharides (LPS) confer resistance to infection.

Area of Science:

  • Veterinary Pathology
  • Microbiology
  • Immunology

Background:

  • Fulminating pneumonia is a severe lung infection.
  • Pseudomonas aeruginosa is a common opportunistic pathogen.

Purpose of the Study:

  • To characterize the pathological effects of Pseudomonas aeruginosa in mink.
  • To evaluate the efficacy of a Pseudomonas aeruginosa lipopolysaccharide (LPS) vaccine.

Main Methods:

  • Intratracheal administration of Pseudomonas aeruginosa to mink.
  • Histopathological examination of lung tissues.
  • Immunofluorescence for antigen detection.
  • Enzyme-linked immunosorbent assay (ELISA) for antibody detection.
  • Vaccine trial using LPS antigen.

Main Results:

  • Progressive pulmonary lesions including inflammation and necrosis were observed.
  • Bacterial spread occurred via airways, leading to secondary lesions.
  • Pseudomonas aeruginosa antigen was detected within lung tissues.
  • Macrophage infiltration was noted in surviving mink.
  • Antibody to LPS was detected post-vaccination and post-natural infection.
  • Mink with LPS antibody showed resistance to experimental infection.

Conclusions:

  • Pseudomonas aeruginosa induces severe, progressive pneumonia in mink.
  • Antibodies against Pseudomonas aeruginosa LPS provide protection against experimental infection.

Related Concept Videos